---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-25-009103"
form_type: "8-K"
ticker: "SBFM"
cik: "0001402328"
company_name: "Sunshine Biopharma Inc."
filed_at: "2025-12-12T23:59:59+00:00"
generated_at: "2026-05-16T13:20:40.088486+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Sunshine Biopharma shareholders elect all five directors and approve equity plan increase at annual meeting

## Summary
- All five director nominees elected: Dr. Slilaty, Sebaaly, Kiderchah, Natan, Keller received over 130M votes for.
- Ratification of M&K CPAS as independent auditor for 2025 approved with 132M for, 178K against.
- Amendment to 2023 Equity Incentive Plan to increase authorized shares to 683,000 approved with 130M for, 294K against.
- Broker non-votes: 1.77M on director elections and equity plan; 0 on auditor ratification.

## SEC filing metadata
- accession: 0001683168-25-009103
- form_type: 8-K
- ticker: SBFM
- cik: 0001402328
- company_name: Sunshine Biopharma Inc.
- filed_at: 2025-12-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1402328/000168316825009103/0001683168-25-009103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1402328/000168316825009103/sunshine_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-25-009103
- JSON: https://secwatch.observer/filing/0001683168-25-009103.json
- Plain text: https://secwatch.observer/filing/0001683168-25-009103.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.